Volume 16, Number 1—January 2010
Skin Lesion Caused by ST398 and ST1 MRSA, Spain1
To the Editor: Human infections caused by methicillin-resistant Staphylococcus aureus (MRSA) sequence type 398 (ST398) have been emerging in recent years in Europe (1,2). Pigs represent a common reservoir of MRSA ST398, and working with these animals may constitute a risk factor for MRSA carriage and possible infection (2–4). We report a case of human infection caused by MRSA ST398 in Spain.
A 12-year-old girl living close to a pig farm, where her father and mother worked, sought treatment for a skin lesion on her chin. Two types of MRSA were recovered from the lesion, and it resolved after topical treatment with mupirocin over 10 days. MRSA isolates recovered were characterized by multilocus sequence typing (MLST) and by staphylococcal cassette chromosome (SCC) mec, spa, and agr typing as described (3). The presence of genes encoding Panton-Valentine leukocidin (PVL) (lukF/lukS), toxic shock syndrome toxin-1 (tsst1), and exfoliative-toxin A and B (eta, etb) was investigated by PCR (2,3). Antimicrobial susceptibility tests were carried out by using the VITEK-2 system (bioMérieux, Marcy l’Etoile, France), and mecA, ermA, ermB, ermC, mrsA, tetK, tetL, tetM, ant(4′)-Ia, aph(3′)-III , and aph(2′)-aac(6′) resistance genes were studied by PCR (5). dfrK gene detection was performed by using primers designed from the sequence FM207105 included in GenBank (dfrK-F 5′-GAGAATCCCAGAGGATTGGG; dfrK-R, 5′-CAAGAAGCTTTTCGCTCATAAA), and the obtained amplicons were sequenced for confirmation. Mutations in quinolone targets were determined by sequence analysis of grlA and gyrA genes (6). In addition, MRSA isolates were typed by pulsed-field gel electrophoresis (PFGE) (www.harmony-microbe.net/microtyping.htm).
One of the clinical MRSA isolates recovered from the lesion and typed as ST398-spa-t011 showed resistance to tetracycline, macrolides, and lincosamides and harbored 5 antimicrobial resistance genes. The second MRSA strain was typed as ST1-spa-t127 and showed a multiresistance phenotype with 11 resistance genes, as well as the Ser80Phe and Ser84Leu amino acid changes in GrlA and GyrA proteins, respectively.
To establish the MRSA nasal colonization status of the patient and of her relatives (father, mother, and brother, all of whom had contact with animals) and to elucidate the possible origin of these strains, we analyzed nasal swabs for MRSA recovery. Nasal samples were plated in oxacillin-resistant S. aureus agar media (Oxoid, Termofisher, UK), colistin nalidixic acid (bioMérieux), and blood agar media (Oxoid); colonies suggestive of S. aureus were initially selected, further identified, and characterized for bacterial typing and antimicrobial resistance mechanisms. Samples from all relatives and the patient showed that all 4 persons were MRSA nasal carriers presenting the following genetic lineages: patient girl, ST398-t108; mother, ST398-t108 and ST1-t127; father, ST398-t108; and brother, ST398-t011 (2 variants) (Table). MRSA t127 and t011 variants detected in the skin lesion of the patient were not found in her nasal sample but were found in the nasal samples of her mother and brother. Another study has been initiated to analyze the presence of MRSA in nasal swabs of swine on the farm.
The ST1-t127 strains obtained from the skin lesion of the girl (C1569) and from the mother’s nasal sample (C1578) showed the same multiresistance phenotype and genotype (Table) and an indistinguishable PFGE pattern. This clonal type seems to be associated with community-acquired MRSA isolates circulating in Europe (7). The animal origin of this MRSA type and its possible transmission from horses and cows to humans has been suggested in previous reports (8,9).
In addition, all family members were colonized by MRSA ST398. All recovered nasal MRSA ST398 strains showed resistance to β-lactams, macrolides, lincosamide, and tetracycline, and 3 strains also showed diminished susceptibility to quinolones. Strain ST398 C1576, recovered from the brother, showed a multiresistance phenotype (Table).
The ST398 strains of our study were classified in the spa-types t011 and t108, 2 of the most frequently described types of the clonal complex 398 (1,4) and were untypeable by PFGE. Most MRSA ST398 strains in our study showed a resistance phenotype that included tetracycline, macrolides, and lincosamides. Tetracycline resistance is a common trait of ST398 and suggests that its use in veterinary medicine may have been implicated in selection of this resistance. The first reports, describing ST398 strains, indicated β-lactams and tetracycline as the unique resistance markers, which were susceptible to other antimicrobial agents. Nevertheless, reports of ST398 showing resistance to other antimicrobial drugs are increasing. One of the ST398 strains from the brother showed an uncommon multiresistance phenotype. Moreover, all the MRSA strains of this study were negative for all tested toxin genes, included PVL, although some ST398 PVL–positive strains have been occasionally described (10).
We report a skin lesion on the daughter of a pig farmer in Spain associated with ST398-t011 and ST1-t127 MRSA strains. The results obtained suggest the specific animal origin of these strains and subsequent transference among family members. Of special interest is the multiresistance phenotype of the clinical and nasal ST1-t127 MRSA clinical strains and of 1 nasal strain belonging to ST398 lineage. Nasal colonization by different ST398 genetic lineages and by other lineages of MRSA as ST1-t127 seems to be frequent in persons living in close proximity to farm animals. Dissemination of MRSA ST398 (and probably also MRSA ST1) in humans who have contact with farm animals, is an emerging problem in Spain.
This study was financially supported by the Project SAF2009-08570 from the Ministerio de Ciencia e Innovación of Spain and FEDER. C.L. has a fellowship FPI from the Ministerio de Ciencia e Innovación of Spain.
- Witte W, Strommenger B, Stanek C, Cuny C. Methicillin-resistant Staphylococcus aureus ST398 in humans and animals, Central Europe. Emerg Infect Dis. 2007;13:255–8.
- Lewis HC, Molbak M, Reese C, Aarestrup FM, Selchau M, Sorum M, Pigs as source of methicillin-resistant Staphylococcus aureus CC398 infections in humans, Denmark. Emerg Infect Dis. 2008;14:1383–9.
- Huijsdens XW, van Dijke BJ, Spalburg E, van Santen-Verheuvel MG, Heck ME, Pluister GN, Community-acquired MRSA and pig-farming. Ann Clin Microbiol Antimicrob. 2006;10:26.
- Voss A, Loeffen F, Bakker J, Klaassen C, Wulf M. Methicillin-resistant Staphylococcus aureus in pig farming. Emerg Infect Dis. 2005;11:1965–6.
- Domínguez E, Zarazaga M, Torres C. Antibiotic resistance in Staphylococcus isolates obtained from fecal samples of healthy children. J Clin Microbiol. 2002;40:2638–41.
- Schmitz FJ, Hofmann B, Hansen B, Scheuring S, Luckefahr M, Klootwijk M, Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus. J Antimicrob Chemother. 1998;41:481–4.
- Otter JA, French GL. The emergence of community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital, 2000–2006. Clin Microbiol Infect. 2008;14:670–6.
- Juhász-Kaszanyitzky E, Jánosi S, Somogyi P, Dán Á, van der Graaf-van Bloois L, van Duijkeren E, MRSA transmission between cows and humans. Emerg Infect Dis. 2007;13:630–2.
- Cuny C, Strommenger B, Witte W, Stanek C. Clusters of infections in horses with MRSA ST1, ST254, and ST398 in a veterinary hospital. Microb Drug Resist. 2008;14:307–10.
- Welinder-Olsson C, Florén-Johansson K, Larsson L, Oberg S, Karlsson L, Ahrén C. Infection with Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus t034. Emerg Infect Dis. 2008;14:1271–2.
Suggested citation for this article: Aspiroz C, Lozano C, Vindel A, Lasarte JJ, Zarazaga M, Torres C. Skin lesion caused by ST398 and ST1 MRSA, Spain [letter]. Emerg Infect Dis [serial on the Internet]. 2010 Jan [date cited]. Available from http://wwwnc.cdc.gov/eid/article/16/1/09-0694
1This study was presented as a poster at the 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland, 2009.
Comments to the Authors
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: March 31, 2011
- Page last updated: March 31, 2011
- Page last reviewed: March 31, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)